Third Ebit from 2010 to 2024
| THRD Stock | USD 12.76 0.35 2.67% |
EBIT | First Reported 2010-12-31 | Previous Quarter -30.8 M | Current Value -32.4 M | Quarterly Volatility 8.7 M |
Check Third Harmonic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Third Harmonic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 36.8 K, Selling General Administrative of 10.4 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.7. Third financial statements analysis is a perfect complement when working with Third Harmonic Valuation or Volatility modules.
Third | Ebit |
Latest Third Harmonic's Ebit Growth Pattern
Below is the plot of the Ebit of Third Harmonic Bio over the last few years. It is Third Harmonic's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Third Harmonic's overall financial position and show how it may be relating to other accounts over time.
| Ebit | 10 Years Trend |
|
Ebit |
| Timeline |
Third Ebit Regression Statistics
| Arithmetic Mean | (17,385,213) | |
| Coefficient Of Variation | (49.84) | |
| Mean Deviation | 6,714,713 | |
| Median | (12,807,000) | |
| Standard Deviation | 8,665,191 | |
| Sample Variance | 75.1T | |
| Range | 24.9M | |
| R-Value | (0.73) | |
| Mean Square Error | 38.1T | |
| R-Squared | 0.53 | |
| Significance | 0 | |
| Slope | (1,408,223) | |
| Total Sum of Squares | 1051.2T |
Third Ebit History
Other Fundumenentals of Third Harmonic Bio
About Third Harmonic Financial Statements
Third Harmonic stakeholders use historical fundamental indicators, such as Third Harmonic's Ebit, to determine how well the company is positioned to perform in the future. Although Third Harmonic investors may analyze each financial statement separately, they are all interrelated. For example, changes in Third Harmonic's assets and liabilities are reflected in the revenues and expenses on Third Harmonic's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Third Harmonic Bio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EBIT | -30.8 M | -32.4 M | |
| EBITDA | -30.8 M | -32.3 M | |
| Ebt Per Ebit | 0.70 | 1.20 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Third Harmonic Bio is a strong investment it is important to analyze Third Harmonic's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Third Harmonic's future performance. For an informed investment choice regarding Third Stock, refer to the following important reports:Check out the analysis of Third Harmonic Correlation against competitors. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Third Harmonic. If investors know Third will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Third Harmonic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.97) | Return On Assets (0.11) | Return On Equity (0.14) |
The market value of Third Harmonic Bio is measured differently than its book value, which is the value of Third that is recorded on the company's balance sheet. Investors also form their own opinion of Third Harmonic's value that differs from its market value or its book value, called intrinsic value, which is Third Harmonic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Third Harmonic's market value can be influenced by many factors that don't directly affect Third Harmonic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Third Harmonic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Third Harmonic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Third Harmonic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.